These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7706134)

  • 1. Structure-activity relationships for interactions between carbapenems and beta-lactamases.
    Sumita Y; Nouda H; Shinagawa H; Yamaga H; Sunagawa M
    J Antibiot (Tokyo); 1995 Feb; 48(2):188-90. PubMed ID: 7706134
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro antimicrobial activity and structure-activity relationship of C-2 triazolylthio and pyridinylmethylthio carbapenems.
    Fiakpui C; Thomas G; Singh MP; Micetich RG; Singh R
    J Antibiot (Tokyo); 1996 Feb; 49(2):212-5. PubMed ID: 8621364
    [No Abstract]   [Full Text] [Related]  

  • 3. Synthesis and in vitro activity of a series 1beta-methylcarbapenem derivatives.
    Jeon HC; Kim JW; Hong JH; Cho JH; Oh CH
    Eur J Med Chem; 2006 Oct; 41(10):1201-9. PubMed ID: 16797791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel 1 beta-methylcarbapenem antibiotic, S-4661. Synthesis and structure-activity relationships of 2-(5-substituted pyrrolidin-3-ylthio)-1 beta-methylcarbapenems.
    Iso Y; Irie T; Nishino Y; Motokawa K; Nishitani Y
    J Antibiot (Tokyo); 1996 Feb; 49(2):199-209. PubMed ID: 8621362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and antibacterial activity of 1 beta-methyl-2-(5-substituted imidazolino pyrrolidin-3-ylthio)carbapenem derivatives.
    Oh CH; Lee CS; Lee JS; Cho JH
    Arch Pharm (Weinheim); 2003 Nov; 336(11):504-9. PubMed ID: 14639742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and antibacterial activities of 4-pyrrolidinylthio carbapenems: containing heteroaromatics as a side chain.
    Cho HW; Oh CH; Lee JS; Lee SC; Choi JH; Cho JH
    Arch Pharm (Weinheim); 2003 Nov; 336(11):495-503. PubMed ID: 14639741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and in-vitro activity of novel 1beta-methylcarbapenems having spiro[2,4]heptane moieties.
    Park HB; Jo NH; Hong JH; Choi JH; Cho JH; Yoo KH; Oh CH
    Arch Pharm (Weinheim); 2007 Oct; 340(10):530-7. PubMed ID: 17849445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and antibacterial activity of 2alpha-functionalized 1beta-methylcarbapenems related to KR-21012.
    Kwak HJ; Pyun DK; Kim JH; Kim EJ; Jeong HJ; Kim BJ; Lee CH
    Bioorg Med Chem Lett; 2000 Feb; 10(4):333-6. PubMed ID: 10714493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative activity of doripenem and three other carbapenems tested against Gram-negative bacilli with various beta-lactamase resistance mechanisms.
    Jones RN; Sader HS; Fritsche TR
    Diagn Microbiol Infect Dis; 2005 May; 52(1):71-4. PubMed ID: 15878447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parenteral carbapenems.
    Shah PM
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():175-80. PubMed ID: 18154543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-vitro activity of a new penem FCE 22101.
    Hoban DJ
    J Antimicrob Chemother; 1989 Mar; 23 Suppl C():53-7. PubMed ID: 2786518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological activities of an alpha-methyl and a beta-methyl carbapenem and the corresponding unsubstituted compound.
    Pfaendler HR; Weishaupt R; Meffert H
    Bioorg Med Chem Lett; 2000 Jun; 10(12):1389-91. PubMed ID: 10890171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of the new quinolones: an overview.
    Garcia-Rodriguez JA
    J Chemother; 1989 Jul; 1(4 Suppl):136-8. PubMed ID: 16312340
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro and in vivo antibacterial activities of CS-023 (RO4908463), a novel parenteral carbapenem.
    Koga T; Abe T; Inoue H; Takenouchi T; Kitayama A; Yoshida T; Masuda N; Sugihara C; Kakuta M; Nakagawa M; Shibayama T; Matsushita Y; Hirota T; Ohya S; Utsui Y; Fukuoka T; Kuwahara S
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3239-50. PubMed ID: 16048932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and antibacterial evaluation of 1beta-methyl-2-[5-(1-methoxyimino-2-substituted sulfonamide ethyl)pyrrolidin-3-ylthio]carbapenems and their related compounds.
    Jeon H; Jo NH; Yoo KH; Choi JH; Cho H; Cho JH; Oh CH
    Eur J Med Chem; 2007 Mar; 42(3):358-64. PubMed ID: 17156896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel C-2 substituted carbapenem derivatives. Part II. Synthesis and structure-activity relationships of isoxazolin-2-yl, isoxazolidin-2-yl and 2-pyrazolin-2-yl carbapenems generated using 1,3-dipolar cycloaddition chemistry.
    Burton G; Clarke GJ; Douglas JD; Eglington AJ; Frydrych CH; Hinks JD; Hird NW; Hunt E; Moss SF; Naylor A; Nicholson NH; Pearson MJ
    J Antibiot (Tokyo); 1996 Dec; 49(12):1266-74. PubMed ID: 9031673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An enzoinformatics study for prediction of efficacies of three novel penem antibiotics against New Delhi metallo-β-lactamase-1 bacterial enzyme.
    Ansari MA; Shaikh S; Shakil S; Rizvi SM
    Interdiscip Sci; 2014 Sep; 6(3):208-15. PubMed ID: 25205498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Microbiology and Infectious Diseases (ECCMID)--18th European Congress. Drug resistance among Gram-negative and Gram-positive bacteria.
    Falagas ME; Karageorgopoulos DE
    IDrugs; 2008 Jun; 11(6):409-11. PubMed ID: 18509779
    [No Abstract]   [Full Text] [Related]  

  • 19. Carbapenems: the pinnacle of the beta-lactam antibiotics or room for improvement?
    Edwards JR; Betts MJ
    J Antimicrob Chemother; 2000 Jan; 45(1):1-4. PubMed ID: 10629005
    [No Abstract]   [Full Text] [Related]  

  • 20. Preparation and antimicrobial assessment of 2-thioether-linked quinolonyl-carbapenems.
    Hershberger PM; Switzer AG; Yelm KE; Coleman MC; Devries CA; Rourke FJ; Davis BW; Kraft WG; Twinem TL; Koenigs PM; Paule SM; Siehnel RJ; Zoutendam PH; Imbus R; Demuth TP
    J Antibiot (Tokyo); 1998 Sep; 51(9):857-71. PubMed ID: 9820237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.